Gumintad, Maximo B.

HRN: 11-94-20  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2026
METRONIDAZOLE 500MG (TAB)
05/25/2026
05/30/2026
PO
750
Q8
Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines